# The New England Journal of Medicine

The New England Journal of Medicine (NEJM) is a weekly medical journal published by the Massachusetts Medical Society. NEJM's 1st edition was published in January 1812 under the journal title New England Journal of Medicine and Surgery and Collateral Branches of Science. NEJM is perhaps the world's most prestigious medical journal.

## Quotes about NEMJ

* The rise of the germ theory was vigorously debated in the Journal in the late 19th century. ... ... With germ theory, the scientific foundation for the use of vaccines, new and old, was at last demonstrated. Compulsory vaccination was a constant topic of debate in the Journal from its earliest years, as it remains in contemporary societies, conveying ongoing tensions between social mandates and individual liberties, the good of the many and the risks to the few. The Journal would report many “firsts” in subsequent years, including the first major quantitative study linking smoking to lung cancer (1928), the introduction of the pulmonary artery catheter (1970), and early clinical descriptions of AIDS (1981). And breakthroughs reported elsewhere quickly found their way to the Journal. Insulin, for example, first described in the Journal of Laboratory and Clinical Medicine in 1922, received extensive review and discussion in the Journal later that year, and many articles analyzing its optimal use in diabetes followed. Myriad new diagnostic technologies accompanied changes in the theory and treatment of disease. The Journal offers a window onto the rise of new medical technologies, from stethoscopes to improved tourniquets, from Wilhelm Roentgen's x-rays to magnetic resonance imaging and beyond. Technologies that probe and visualize the body represented a critical aspect of the development of modern medical practice and the conceptualization of pathologies. The focus on disease specificity and causal mechanism that emerged with the germ theory would ultimately drive research at the molecular and genetic level that continues to be reflected in the Journal.
** Allan M. Brandt, (2012)"A Reader's Guide to 200 Years of the New England Journal of Medicine". New England Journal of Medicine 366 (1): 1–7. DOI:10.1056/NEJMp1112812.
* The New England Journal of Medicine is facing criticism for publishing a scathing review of a book which claimed that industrial and environmental pollutants may be responsible for outbreaks of cancer. The review was written by Dr Jerry Berke, the medical director of W R Grace, a chemical company currently being blamed for polluting drinking water in a Boston suburb and for contaminating soils in Maryland with thorium.
** Deborah Josefson, (1998)"US journal embroiled in another conflict of interest scandal". BMJ 316 (7127): i. DOI:10.1136/bmj.316.7127.247i.
* The New England Journal of Medicine was made great by Franz Ingelfinger, who banged on every important door in Boston urging researchers to admit their best studies to the journal. The journal assumed the effortless but often genuine superiority of Bostonians so well described—but also ridiculed—by Henry James. ... To some this felt like arrogance, and the journal has always been hated as well as admired. Often the motivation for such hatred may have been jealousy or resentment at failure to make it into its hallowed pages. Ingelfinger was followed by Bud Relman, and the journal grew richer as well as grander. The Massachusetts Medical Society, the owner of the journal, made US$88m from publishing in 2005. My guess is that the journal accounts for at least US$75m of that and that its profits are probably at least US$15m. The society has grown fat on the profits and is keen not only to keep the profits coming but also to exploit the brand. This has led to tensions between the journal and the society, and those tensions were in many ways the undoing of Jerry Kassirer and Marcia Angel, the successors to Relman. Both Angel and Kassirer after leaving the journal published books bemoaning the excessive influence of the drug industry, ... while the society appointed a new editor, Jeff Drazen, who was depicted by some as a creature of the industry. ... He had had financial connections with 21 drug companies between 1994 and 2000.
** Richard Smith, (2006)"Lapses at the New England Journal of Medicine". Journal of the Royal Society of Medicine 99 (8): 380–382. DOI:10.1177/014107680609900802.
* At a recent cardiology conference in New Delhi, the cardiologist Deepak Natarajan raised the concern that commercial conflicts of interest (COIs) were corrupting medical journals ... Natarajan cited “manipulated” publications in The New England Journal of Medicine (NEJM) as one example to support his view. His comments were met with silence and an air of indignation. Natarajan’s medical colleagues were stunned, disbelieving, and then, angry. Their response stemmed in part from the NEJM’s reputation as the premier medical journal in the world. The NEJM has the highest impact of any medical journal and physicians tend to see the NEJM – to use Natarajan’s words – as “the holy grail of publishing” ... Physicians wear their NEJM publications as a badge of prestige given the journal’s reputation and influence. But as Natarajan noted, so do research sponsors who compete to have their research studies published in the NEJM to influence prescribing habits of physicians and increase drug market share. Journals can profit handsomely from research sponsors buying reprints of their studies to distribute to physicians. And the NEJM does not make public what it earns from reprints.
** Mark Wilson, (2016). "The New England Journal of Medicine: commercial conflict of interest and revisiting the Vioxx scandal". Indian Journal of Medical Ethics 1 (3): 167–171.

## See also

* Health care
* History of medicine
* Medicine
* Pharmaceutical industry
* Physicians

## External links

* Encyclopedic article on The New England Journal of Medicine on Wikipedia}